# Celldex Therapeutics Inc. (CLDX) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $39.68, market value $3.1 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Celldex Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2016.9×**. Each dollar of revenue is priced at 2016.9×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 4.4×**. The shares trade at 4.4× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -7.8%**. Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -49.1%**. Return on equity is negative because earnings are negative.
- **Return on assets: -44.4%**. Each dollar of assets produces -44.4% of profit.

## Growth
- **Revenue growth (1 yr): -78.0%** (3-yr -13.1%/yr, 5-yr -26.9%/yr). Revenue fell 78.0% over the last year, against -26.9% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -59.2%**. Earnings per share fell 59.2%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 10.49** (quick 10.49). Current assets cover the next year's liabilities 10.49 times.
- **Altman Z-score: 34.13**. A Z-score of 34.13 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Celldex Therapeutics Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 74.2%** (YTD 46.1%, 3-mo 38.6%). The shares are up 74.2% over twelve months including dividends.
- **From 52-week high: -12.1%** (79.5% above the low). Trading 12% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 49**. An RSI of 49 is neutral.
- **Beta (1 yr): 1.38** (volatility 50%). Beta of 1.38 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CLDX · Page: https://foliofundamentals.com/stocks/cldx

Not investment advice.